CurrentCardio
Get Weekly

Topic · page 37 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,441–1,480 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. J Am Coll Cardiol

    Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials

    Secondary analysis

  2. Eur J Heart Fail

    Expansion of the National Amyloidosis Centre Staging System to Detect Early Mortality in Transthyretin Cardiac Amyloidosis

    Diagnostic or prognostic study

  3. Eur J Heart Fail

    Geographical Variation in Patient Characteristics and Outcomes in Heart Failure with Mildly Reduced and Preserved Ejection Fraction

    Meta-analysis

  4. Eur J Heart Fail

    Incremental Value of C-Reactive Protein to the MEESSI Acute Heart Failure Risk Score

    Diagnostic or prognostic study

  5. J Am Coll Cardiol

    Semaglutide and NYHA Functional Class in Obesity-Related Heart Failure With Preserved Ejection Fraction: The STEP-HFpEF Program

    Meta-analysis

  6. Eur Heart J

    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial

    Randomised controlled trial

  7. Eur J Heart Fail

    Diabetic Myocardial Disorder. A Clinical Consensus Statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases

    Guideline or statement

  8. Eur J Prev Cardiol

    Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT

    Guideline or statement

  9. JACC CardioOncol

    Race and Socioeconomic Status Impact Diagnosis and Clinical Outcomes in Transthyretin Cardiac Amyloidosis

    Cohort study

  10. J Am Coll Cardiol

    SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy

    Cohort study

  11. JACC Heart Fail

    Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF

    Randomised controlled trial

  12. Eur Heart J

    Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study

    Cohort study

  13. JAMA

    Prognostic Value of Cardiovascular Biomarkers in the Population

    Meta-analysis

  14. Eur J Heart Fail

    Right Heart Failure with Left Ventricular Assist Devices: Preoperative, Perioperative and Postoperative Management Strategies. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC

    Guideline or statement

  15. Eur J Heart Fail

    Percutaneous Repair of Moderate-to-Severe or Severe Functional Mitral Regurgitation in Patients with Symptomatic Heart Failure: Baseline Characteristics of Patients in the RESHAPE-HF2 Trial and Comparison to COAPT and MITRA-FR Trials

    Randomised controlled trial

  16. Eur Heart J

    Loop diuretic therapy with or without heart failure: impact on prognosis

    Cohort study

  17. JACC Heart Fail

    Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2

    Secondary analysis

  18. Eur J Heart Fail

    Cardiac Function, Haemodynamics, and Valve Competence with Exercise in Patients with Heart Failure with Preserved Ejection Fraction and Mild to Moderate Secondary Mitral Regurgitation

    Cohort study

  19. Eur J Heart Fail

    A Nationwide, Population-Based Study on Specialized Care for Acute Heart Failure Throughout the COVID-19 Pandemic

    Cohort study

  20. JAMA

    Cardiovascular Burden of the V142I Transthyretin Variant

    Meta-analysis

  21. Eur J Heart Fail

    Mechanisms of Myocardial Reverse Remodelling and Its Clinical Significance: A Scientific Statement of the ESC Working Group on Myocardial Function

    Guideline or statement

  22. Eur J Prev Cardiol

    Prognosis and treatment strategies for atrial fibrillation in heart failure with mildly reduced ejection fraction

    Cohort study

  23. JAMA Cardiol

    Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis

    Meta-analysis

  24. JAMA Cardiol

    Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021

    Cohort study

  25. JACC Heart Fail

    Autoimmune Disorders in Heart Failure With Preserved Ejection Fraction

    Cohort study

  26. Eur J Heart Fail

    Impact of Malnutrition in Patients with Severe Heart Failure

    Cohort study

  27. Circulation

    Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy

    Diagnostic or prognostic study

  28. Eur J Heart Fail

    Sacubitril/Valsartan for the Treatment of Non-Obstructive Hypertrophic Cardiomyopathy: An Open Label Randomized Controlled Trial (SILICOFCM)

    Randomised controlled trial

  29. Eur J Heart Fail

    Balcinrenone Plus Dapagliflozin in Patients with Heart Failure and Chronic Kidney Disease: Results from the Phase 2b MIRACLE Trial

    Randomised controlled trial

  30. Eur J Heart Fail

    Differences in Presentation, Diagnosis and Management of Heart Failure in Women. A Scientific Statement of the Heart Failure Association of the ESC

    Guideline or statement

  31. Eur J Heart Fail

    How to Tackle Therapeutic Inertia in Heart Failure with Reduced Ejection Fraction. A Scientific Statement of the Heart Failure Association of the ESC

    Guideline or statement

  32. Eur Heart J

    Risk of heart failure in inflammatory bowel disease: a Swedish population-based study

    Cohort study

  33. Eur J Heart Fail

    Intentional Weight Loss in Overweight and Obese Patients with Heart Failure: A Systematic Review

    Meta-analysis

  34. JACC Heart Fail

    Association of High-Density Lipoprotein Parameters and Risk of Heart Failure: A Multicohort Analysis

    Meta-analysis

  35. Eur J Heart Fail

    On-Treatment Analysis of Torsemide Versus Furosemide for Patients Hospitalized for Heart Failure: A Post-Hoc Analysis of TRANSFORM-HF

    Secondary analysis

  36. J Am Coll Cardiol

    Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy

    Secondary analysis

  37. Eur J Heart Fail

    Frailty According to the 2019 HFA-ESC Definition in Patients at Risk for Advanced Heart Failure: Insights from the HELP-HF Registry

    Cohort study

  38. J Am Coll Cardiol

    Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies

    Cohort study

  39. Eur J Heart Fail

    404-Error “Disease Not Found”: Unleashing the Translational Potential of -Omics Approaches Beyond Traditional Disease Classification in Heart Failure Research

    Research article

  40. N Engl J Med

    Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Randomised controlled trial

All 1,928 Briefs in ExploreShowing Briefs 1,441–1,480 of 1,928, newest first